Drug details
Eysuvis (loteprednol etabonate ophthalmic suspension)
type of Corticosteroids, Ophthalmic
Eysuvis (loteprednol etabonate ophthalmic suspension) is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
This drug may have the following side effects:
- instillation site pain and
The following drugs are related to Eysuvis, either as a replacement or used together:
- Restasis (cyclosporine)
- Restasis MultiDose (cyclosporine ophthalmic emulsion)
- Xiidra (lifitegrast ophthalmic solution, 5%)
- Miebo (perfluorohexyloctane ophthalmic solution)
- Tyrvaya (varenicline solution nasal spray)